SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
白踏歌
Lv5
940 积分
2021-09-16 加入
最近求助
最近应助
互助留言
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification
4天前
已完结
Immunotherapy in renal cell carcinoma
9天前
已完结
Renal Cell Cancer – Insights in Drug Resistance Mechanisms
9天前
已完结
Renal Cell Cancer
9天前
已完结
Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial
1个月前
已完结
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
1个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
1个月前
已完结
[Standardize the diagnosis and treatment of drug-induced liver injury, and strengthen clinical and translational research]
1个月前
已完结
Improving survival from metastatic, recurrent, or persistent cervical cancer
2个月前
已完结
Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer
2个月前
已完结
没有进行任何应助
内容不符合,文件打不开
10个月前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论